v3.26.1
Segments of business and geographic areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 29, 2026
Mar. 30, 2025
Segment Reporting Information [Line Items]    
Restructuring (Note 12) $ 32 $ 17
Sales to customers (Note 9) 24,062 21,893
Cost of products sold 8,106 7,357
Selling, marketing and administrative expenses 6,034 5,112
Research and development expense 3,527 3,225
Other (income) expense, net (294) 7,321
Earnings before provision for taxes on income 5,990 13,631
Less: Expense not allocated to segments 566 (7,000)
Innovative Medicine    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 15,426 13,873
MedTech    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 8,636 8,020
Acquisition related costs   100
MedTech | Separation Related Costs    
Segment Reporting Information [Line Items]    
Restructuring (Note 12) 100  
General Corporate | Talc    
Segment Reporting Information [Line Items]    
Litigation expense 300  
Reversal of fee expense   7,000
Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring (Note 12) 62 55
Earnings before provision for taxes on income 6,556 6,631
Operating Segments | Innovative Medicine    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 15,426 13,873
Cost of products sold 4,390 4,020
Selling, marketing and administrative expenses 2,918 2,261
Research and development expense 2,813 2,548
Other (income) expense, net (12) (166)
Earnings before provision for taxes on income 5,317 5,210
Amortization 800 600
Operating Segments | MedTech    
Segment Reporting Information [Line Items]    
Restructuring (Note 12) 7 55
Sales to customers (Note 9) 8,636 8,020
Cost of products sold 3,701 3,326
Selling, marketing and administrative expenses 2,906 2,656
Research and development expense 714 677
Other (income) expense, net 76 (60)
Earnings before provision for taxes on income 1,239 1,421
Amortization $ 500 $ 500